Who Paid My Doc
Acp-103-042
ClinicalTrials.gov NCT03018340
Research payments
$353,486
Through program year 2020, $353,486 in research payments was reported against Acp-103-042, across 51 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT03018340
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $24,356 | 12 |
| 2019 | Research | $329,130 | 39 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Jelena Kunovac Oceanside, CA Named on 4 payments
- Michael Downing Dallas, TX Named on 4 payments
- David Purselle Decatur, GA Named on 3 payments
- Sarah Atkinson Rochester, NY Named on 3 payments
- John Joyce Jacksonville, FL Named on 3 payments
- Martin Schuster Sherman Oaks, CA Named on 3 payments
- Corinna Gamez San Francisco, CA Named on 3 payments
- Michael Thase Philadelphia, PA Named on 3 payments
- Boadie Dunlop Atlanta, GA Named on 3 payments
- Gianni Faedda New York, NY Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.